VCRE 6-K: SEC filing
Vicore Pharma
Filed with the SEC on · accession 0001437749-26-035333
VCRE filed a 6-K (foreign company report) with the SEC on Nov 5, 2026. Vicore Pharma reported Q3 2026 financial results with a net loss of SEK 124.3 million and cash of SEK 772.0 million, and announced that the independent Data Monitoring Committee recommended the Phase 2b ASPIRE trial of buloxibutid in IPF continue without modification following a pre-planned…
Summary of the filing
Vicore Pharma reported Q3 2026 financial results with a net loss of SEK 124.3 million and cash of SEK 772.0 million, and announced that the independent Data Monitoring Committee recommended the Phase 2b ASPIRE trial of buloxibutid in IPF continue without modification following a pre-planned futility analysis.
Key details
✦ Ask GOAX AI about this filing — what it means for VCRE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for VCRE?
Click hereFrequently asked questions
What did VCRE file with the SEC on Nov 5, 2026?
VCRE filed a 6-K (SEC filing). Vicore Pharma reported Q3 2026 financial results with a net loss of SEK 124.3 million and cash of SEK 772.0 million, and announced that the independent Data Monitoring Committee recommended the Phase 2b ASPIRE trial of buloxibutid in IPF continue without modification following a pre-planned futility analysis.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
Other VCRE SEC filings
Get alerts when VCRE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days